BackPortola Pharmaceuticals Overview

Portola Pharmaceuticals Other Liabilities

Latest other liabilities for PTLA: $0.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

Portola Pharmaceuticals Other Liabilities History

Loading

Portola Pharmaceuticals vs. peers: Other Liabilities Comparison

Loading

Portola Pharmaceuticals Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Portola Pharmaceuticals (PTLA) FAQ

Portola Pharmaceuticals (PTLA) currently reports a other liabilities of $0 as of March 2020. In the prior-year period, the figure was $0. Use the charts on this page to explore Portola Pharmaceuticals's other liabilities history and peer comparisons.

Portola Pharmaceuticals's other liabilities changed from $0 to $0 (period ending March 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Portola Pharmaceuticals reported $0 in other liabilities as of March 2020. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other liabilities of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Portola Pharmaceuticals, and consider following PTLA for alerts when major investors trade the stock.

Portola Pharmaceuticals is classified in the Healthcare sector. On other liabilities, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PTLA with unrelated industries.